Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRME in Barrett's Esophagus
NCT02018367Phase 2Unknown
- Start
- Sep 2012
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms). Primary endpoints: Diagnostic yield of HRME with directed biopsy at 1 day and Clinical impact of HRME on diagnosis and surveillance at 1 day. Status: unknown.
Beyond the preview
Go deeper on NCT02018367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02018367.